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Abstract: Phyto-chemicals are increasingly being used in the treatment of cancer because of their availability, potential anti-cancer 
activity with less adverse effects when compared with chemotherapy. The variation of climate and geography in South Asian  
countries provides a nursing environment for the growth of versatile plant species, that are repeatedly drawing attention of the  
scientific community. In this review, we have focused on the anti-cancer potential of thirty plants, which are commonly found in 
Bangladesh, India, Nepal, Pakistan and Sri Lanka, with their mechanisms of action. In particular, we have discussed the bio-active 
components that display anti-cancer activity, which have been identified in these plants. This review may help researchers to profile 
plants with known anti-cancer effect of this region and further investigations of anti-cancer agents in medicinal plants from South 
Asia. 
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1 Phyto-chemicals, as Anti-cancer Agents 
In the last century, significant development in bio-medical 
science has conquered many diseases, however cancer remains 
ambiguous especially from a therapeutic perspective. Cancer is 
still a growing health problem world-wide, and it is the second 
most common cause of death from disease after myocardial 
infarction. Tumor or neoplasm is usually defined as a growth 
of an abnormal mass of tissue due to uncontrolled cellular 
growth, while cancer is the term of all malignant tumors1. 
Non-lethal genetic damage by multi-step carcinogenesis 
allows for the neoplastic transformations, such as self-
sufficiency in growth signal, insensitivity to growth-inhibitory 
signal, evasion of apoptosis, limitless replication, sustained 
angiogenesis and the ability to invade and metastasize2. 
However, cancer to some degree is a preventable disease, as 
cancer risk can be reduced by avoidance of cancer-causing 
biological, chemical, and physical agents, in addition to the 
habitual consumption of cancer protective foods3. Current 
research emphasis focuses on synthetic chemotherapeutic 
drugs but unfortunately conventional chemotherapy with 
synthetic drugs evoke severe side effects. 
There are thousands of scientific studies that have focused 
on the pharmacological activity of bio-active components from 
plants, increasing interest from scientific community as 
cancers suppressant. Biological targets of phyto-chemicals in 
mammalian cells were found to be involved in inflammatory 
processes and oncogenic transformation, such as the alteration 
of cell cycle control, apoptosis evasion, angiogenesis and 
metastases4. Additionally, epidemiological studies suggest that 
the daily intake of certain phyto-chemicals can reduce the 
incidence of several types of cancers5. Thus, chemoprevention 
by dietary phyto-chemicals alone immerges as one of the most 
promising approaches for reduced risk of cancer development. 
On the other hand, phyto-chemicals act in synergy with 
chemotherapeutic drugs to overcome cancer cell drug 
resistance, and further application of specific phyto-chemicals 
may also allow the use of lower concentrations of drugs in 
cancer treatment with an increased efficacy6. Interestingly, 
according to WHO, approximately 80% of the world’s 
inhabitants rely on traditional plant derived medicine for their 
primary health care7. Investigation of the underlying 
pharmacokinetic mechanisms through which phyto-chemicals 
evoke their anti-cancer effect introduces a panel of molecular 
targets. This panel includes apoptotic proteins (i.e. caspases, 
bax etc), protein kinases (i.e., PKA, PKC, MAPK, TYK2 etc), 
anti-apoptotic proteins (i.e., bcl2, TRAF1, Survivin etc), 
Growth factors (i.e., TNF, EGF, FGF, PDGF etc), 
transcription factors (i.e., Ap1, NF-κB, Nrf2, p53 etc), cell 
adhesion molecules (i.e., ICAM-1, VCAM etc) and cell cycle 
proteins (i.e., Cyclin D, CDK1, CDK2, p27, p21 etc). 
Moreover, phyto-chemicals interfere with multiple cell-
signaling pathways8. A schematic diagram of the common 
anti-cancer mechanisms of phyto-chemicals has been depicted 
in Figure 1. 
In South Asia, the extraordinary variation in climate and 
geography provides a vast spectrum of environmental  
conditions for the growth of versatile plant species, that are 
repeatedly drawing attention from the scientific community. In 
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this review, we have focused on the anti-cancer potential of 
certain herbal plant species which are commonly grown in 
South Asian countries such as, Bangladesh, India, Nepal,  
Pakistan and Sri Lanka. We have searched databases such as 
Pubmed, Google Scholar, Hinari and AGORA for the basic 
and clinical research publications relating to the anti-cancer 
effects of these plants. In this review, we have included only 
those plants, which are commonly found in a broad spectrum  
range of South Asia, and excluded plant species, which have 
narrow spectrum of habitat. 
 
2 South Asian Plants with Anti-cancer Activities 
Different species of plants from South Asian countries have 
been reported to have anti-cancer potential (Table 1). Some of 
these plants are endemic world-wide, while some are strictly 
native. 
 
Figure 1.  Possible modes of action executed by phyto-chemicals against cancer. Multi-step carcinogenesis through 
cancer-causing agents propels normal cells to divide uncontrollably by apoptosis evasion. The ultimate result is the neoplastic 
transformation of normal cells. Additional tumor progression through clonal proliferation, immune evasion and angiogenesis leads 
non-metastatic tumor that usually metastasizes to a secondary site after the loss of adhesiveness and diversification. Preventive and 
anti-mutagenic phyto-chemicals halt or retard the progression of normal and precancerous cells respectively into malignant, or 
reverse the promotion stage of multi-step carcinogenesis. Anti-proliferative phyto-chemicals inhibit cell growth and proliferation 
while apoptosis inducer phyto-chemicals induce apoptosis of neoplastic cells. Another pronounced impact of phyto-chemicals is the 
prevention of metastasis and angiogenesis2,3,8. 
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Table 1. Summary of the anti-cancer activities of some selective South Asian plants 
name of the plants bio-active compounds experimental models mechanisms of action ref. 
Abrus precatorius 
L. 
protein fraction of seed  
extract, abrin-a, and abrin-b 
Yoshida sarcoma, 
Fibrosarcoma, DLA, 










aqueous extract, embilins (5-O-
ethylembelin and 5-O-
methylembelin) 
AGS, HT-29,  
MDA-MB-435S, 
HL-60, Bel-7402, 
U937 and HeLa 
cytotoxicity, G0/G1 
















organic solvent extracts, amooranin, 
rohitukine 






prostrate, colon and 
gastric cancer cell 
lines 
cytotoxicity, cell cycle 
arrest G2/M phase, 
caspase-activated 
apoptosis, growth  
inhibition through 
cyclin-dependent  
kinases (CDK2 and 
CDK1) 
(22,23,25–27) 
Blumea lacera L. 
methanol extract,  
thymoquinol dimethyl ether,  
β-caryophyllene,  
α-humulene and E-β-farnesene 
AGS, HT-29, MDA-
MB-435S, K562, 
L1210, P3HR1 and 
U937  
cytotoxicity, reactive 





polar extracts, ent-kaurane  




and K562  
cytotoxicity (12,32–34) 
Calotropis procera 
organic extracts and latex, heat-stable 
latex proteins and cardiotonic steroid 
UNBS1450 
HL-60, HCT-8, B-
16/F10, Sarcoma 180 
and Hepatocellular 
carcinoma 




induction of  
autophagy-related cell 






aqueous and organic  
(chloroform and ethanol) extract, 
Cuscutin, amarbelin, β-sterol,  
stigmasterol, kaempferol, dulcitol,  
myricetin, quercetin,  
coumarin and oleanolic acid 
EAC, Hep3B 
cytotoxicity, p53 and 
Bax up-regulation, 
Bcl-2 and survivin 
down regulation  
(40–42) 
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hydroalcoholic and ethanol extract, 
quercetrin, catechin, gallic acid, 
chebulinic acid, oleonolic acid,  
β-amyrin-0-acetate, leucocynidin,  
β-sitosterol and stigmasterol 






petroleum ether fraction, kaempferol-
3,5-dimethyl ether, caryatin,  
(L)-catechin, myricetin,  
quercetin-3-O galactopyranoside,  
myricetin-3-O-galactopyranoside,  
myricetin-3-O-glucopyranoside and  
diosbulbin B 
HepA, cervical  
carcinoma U14, 
S180 and H22 
apoptosis induction, 
immune modulation (48–51) 
Embelia ribes 
Burm. F. 
embelin, quercitol, flavonoids,  








cell cycle arrest at in 
sub G1 phase, down-
regulation of Bcl-2, 
Bcl-xL, survivin, IAP-





methanol extract, lupeol, psoralen and 
β-sisterol HepG2 and MCF-7 cytotoxicity (58–62) 
Ficus religiosa L. polar extract, quercetin and qyricetin, stigmasterol and β-sitosterol 
HT29, MDA-MB-
435S, MCF-7 cytotoxicity (12,63,64) 
Hibiscus tiliaceus 
Linn. 
aqueous extract,  
stigmasterol β-sitosterol, quercetin, 
kaempferol 
DAL, Gastric cancer 
and Colon cancer cytotoxicity (12,65–67) 
Jatropha  
gossypiifolia L. 





effect, cytotoxicity (68–71) 
Kaempferia  
parviflora Wall. 







induction of apoptosis, 
caspase activation (72–74) 
Lantana camara L. camaraside and lantadene-A, HL-60 
cell proliferation  
inhibition, caspase-3 
dependant apoptosis, 
Bcl-2 down regulation 




alcoholic (methanol and  
ethanol) extract, mollic acid  
arabinoside and mollic acid xyloside 
EAC, Ca Ski, MCF-
7, MDA-MB-435, 
KB, HEP G2 and 
WRL 68 
growth inhibition, 
proliferative cell  
nuclear antigen  
expression decrease, 
S- and G2/M- phases 
cell cycle arrest 
(78–80) 
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Mollugo  
pentaphylla Linn. 
apigenin and mollupentin,  
mmollugogenol A,  
mollugogenol B,  
mollugogenol D, oleanolic acid and 
β-sitosterol 
DMBA-induced 
cancer, Sarcoma-180 cytotoxicity (81–83) 
Murraya koenigii 
Linn. 
nnon-polar extract,  
mahanine, mahanimbicine and  
mahanimbine,  
terpenoids 
DAL, MCF-7, HeLa, 
P388, MOLT-3 and 
HL-60 
apoptosis induction by 





liensinine, neferine,  
pronuciferine, isoliensinine, 
negferine, asimilobine,  
nuciferine, remrefidine, isoliensinine, 
flavonoids, flavonol, myricetin,  
quercetin, leucocyanidin, kaempferol, 
astragalin 
EAC, HBL-100, 
Calu-6 human  
pulmonary  
carcinoma and 
SMU-601 and  
Human  
osteosarcoma cells 
inhibition of growth, 
cytotoxicity, p21-
dependent cell cycle 






alcoholic (ethanol and methanol) 
extract,  
glycosides including iridoid  
glycosides, phenylpropanoid  
glycosides, carotenoid  
glucosides, phenylpropanoid  
glycoside cardiac  
glycosides, polysaccharides,  
β-sitosterol, β-amyrin,  
hentri-acontane benzoic acid,  
nyctanthic acid, friedelin, lupeol, 
oleanolic acid, 6β-hydroxylonganin 
alkaloids, phlobatanins, terpenoids 
DAL, MDA-MB 231 
breast cancer cell cytotoxicity (92–95) 
Oxalis corniculata 
Linn. ethanol extract  EAC growth inhibition (96) 




growth inhibition by 
apoptotic pathways, 























organic extract, tannins, β-amyrin, 
lupeol,  
chalcinasterol, β-sitosterol,  
stigmasterol 
EAC cytotoxicity (104,105) 
Solanum nigrum 
Linn. 
crude polysaccharides,  
polyphenols, gentisic acid, luteolin, 
apigenin, kaempferol,  
m-coumaric acid,  
anthocyanidin, Lunasin 
HepG2, AU565,U14, 
mammalian cells and 
skin cancer 
induction of apoptosis 
and/or autophagocytosis,
inhibition H3 and H4 
acetylation inhibition, 
Rb protein  
phosphorylation  
(106–109) 
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Tinospora crispa 
crude polar extract,  













231, HeLa and 3T3 




hexane and ethyl acetate extracts, 
flavonoids, terpenoids EAC growth inhibition (113,114) 
Vitex negundo L. 
organic (chloroform, acetone and 





L-929, DAL, breast, 







2.1 Abrus precatorius L.: Abrus precatorius L. is a  
deciduous dextrose climber with slender flexible branches. It 
is commonly known as ‘Indian liquorice’ and belongs to the 
Fabaceae family. A. precatorius is known in local languages as 
‘Kunch’ in Bangladesh, ‘Guncha’ in India, ‘Olida’ in Sri 
Lanka, ‘Ratigedi’ in Nepal and ‘Ghunchchi Surkh’ in Pakistan. 
The early finding of anti-cancer activity of A. precatorius 
comes from the study by Reddy and Sirsi9. They identified a 
protein, isolated from the seeds of A. precatorius, which  
exhibited anti-tumor activity against Yoshida sarcoma in rats 
and fibrosarcoma in mice. They also observed an association 
of the anti-tumor activity with a cytotoxic effect on the tumor 
cells9. In a short term toxicity study using Dalton’s lymphoma 
ascities (DLA) cells, A. precatorius seed extracts showed anti-
tumor activity. The crude extract of A. precatorius seeds and 
its fractions also displayed cytotoxicity against small cell lung 
carcinoma (A549 cell line)10. Two varieties of this toxic  
protein (Abrin-a, and Abrin-b) were purified from the seeds of 
A. precatorius, which were similar but not identical11.  
Interestingly, Abrin-a, and Abrin-b agglutinated Sarcoma 180 
cells and Ehrlich ascites tumor cells in vitro. It was postulated 
that Abrin-a, and Abrin-b might have ameliorate immune  
responses towards target cells through agglutination associated 
anti-body response. Moreover, both of these two proteins 
could have inhibited the growth of Ehrlich ascites tumor cells 
at a sub-lethal dose when tumor cells were injected  
simultaneously with these proteins in vivo11. 
 
2.2 Aegiceras corniculatum L.: Aegiceras corniculatum L. 
is a species of shrub or tree mangrove in the Myrsinaceae  
family. Its distribution is in the coastal and estuarine areas of a 
region ranging from India, Sri Lanka, Bangladesh through 
South East Asia to southern China, New Guinea and Australia. 
‘Black Mangrove’ is the common name of A. corniculatum. It 
is locally known as ‘Khalsi’ in Bahgladesh, ‘Heen kadol’ in 
Sri Lanka and ‘Halsi’ in India. Aqueous extract of A. cornicu-
latum showed selective cytotoxicity against human gastric 
adenocarcinoma cell line AGS, human colorectal adenocarci-
noma cell line HT-29, and human breast ductal carcinoma cell 
line MDA-MB-435S AGS, HT-29 and MDA-MB-435S12. 
Investigation of the chemical constituent showed the presence 
of several anti-cancer phyto-chemicals in the stems and twigs 
of the mangrove plant, A .corniculatum, of which embilins are 
known to have chemopreventive effects13. Both, 5-O-
ethylembelin and 5-O-methylembelin are promising anti-
mitotic and anti-cancer molecules, which target microtubular 
proteins. These molecules showed in vitro cytotoxicity against 
the HL-60, Bel-7402, U937, and HeLa human cancer cell 
lines14. Mechanistically, 5-O-ethylembelin (1) and 5-O-
methylembelin (2) can induce G0/G1 cell cycle arrest while 
completely disassemble the microtubule network in HL-60 
cells15. 
 
2.3 Alangium salviifolium Wang.: Alangium salviifolium 
Wang. is a deciduous, rambling shrub or a tree belonging to 
the family Alangiaceae. ‘Sage-leaved alangium’ is the  
common name of A. salviifolium, and it is locally known as 
Ankor Kanta (Bangladesh), Angol (India) and Ruk anguna (Sri 
Lanka). Reports propose its use as an anti-diabetic, anti-
epileptic, analgesic and anti-inflammatory, in particular the 
activities of the polar (chloroform-, ethanol-, and aqueous-) 
extracts of A. salvifolium seeds16. Chloroform extract of A. 
salvifolium flower displays anti-tumor effect against Ehrlich 
ascites carcinoma (EAC) in mice17. Intra-peritonial  
administration of the non-polar extracts of A. salvifolium  
flower at a dose of 10 mg/Kg, mimicked the anti-cancer  
activity of bleomycine in EAC bearing mice18. Biologically 
active ingredients of A. salvifolium include flavinoids,  
glycosides, alkaloids and saponins19,20. Nine protoberberine 
alkaloids have been isolated from A. salviifolium, among 
which, 27-O-trans-caffeoylcylicodiscic acid (3) and myriceric 
acid B (4) exhibited cytotoxic activity towards the MOLT-3 
cell line, while 3-O-demethyl-2-O-methylalangiside (5)  
selectively inhibited the growth of the HepG2 cancer cell 
line21. 
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2.4 Amoora rohituka Roxb.: Amoora rohituka Roxb., is a 
species of the Meliaceae family, and commonly known as 
‘Rohituka’. It is locally known as ‘Royna’ in Bangladesh, and 
‘Harin-hara’ in India. Both in vivo and in vitro investigation 
flourished the anti-cancer effect of A. rohituka. Organic  
solvent extracts of A. rohituka bark have been reported to have 
significant anti-tumor activity against DLA and EAC in mice, 
and further its selective cytotoxic activity against breast cancer 
cell line MCF-7 and DLA cells22,23. Amooranin, a triterpenic 
acid extracted from the bark of A. rohituka trees, has  
significant anti-cancer potential against N-nitrosomethyl urea-
induced mammary adenocarcinoma in rats and SW620 human 
colon carcinoma xenograft in mice24. The cytotoxicity of 
Amooranin against a panel of cancerous cell line including 
human mammary carcinoma MCF-7, breast carcinoma MDA-
468, multi-drug resistant breast carcinoma MCF-7/TH, multi-
drug-resistant leukemia (CEM/VLB), colon carcinoma 
(SW620/Ad-300) provides an insight to the possible mode 
action of A. rohituka. Cell cycle arrest at G2/M phase and  
induction of apoptosis via caspase activation pathway are  
likely to contribute to the cytotoxicity of amooranin25,26.  
Furthermore, flavopiridol (6) is a novel semi-synthetic flavone 
analogue of rohitukine (7), chromone alkaloid isolated from an 
A. rohituka, that possess significant anti-cancer activity against 
non-Hodgkin’s lymphoma, renal, prostrate, colon, and gastric 
cancers. It inhibits the tumor growth via cyclin-dependent 
kinases (CDK2 and CDK1) inhibition and inducing apoptosis 
in cancerous cells27. Therefore, rohitukine might have similar 
or partial mechanism to exert its anti-cancer effects of A.  
rohituka. 
 
2.5 Blumea lacera L.: Blumea lacera L., is an annual  
flowering herb, and belongs to Asteraceae family. ‘Malay 
Blumea’ is the common name of B. lacera, and is locally 
known as Kukursanga (Bangladesh), Kudaraundha (India) and 
Kukukuruduru (Sri Lanka). Methanolic extract of B. lacera 
leaves have showed non-selective cytotoxic activity against 
human gastric adenocarcinoma cell line AGS, human colorec-
tal adenocarcinoma cell line HT-29, and human breast ductal 
carcinoma cell line MDA-MB-435S12. A broad spectrum anti-
leukemic activity of B. lacera has also been documented 
against K562, L1210, P3HR1 and U937 leukemia cells28.  
Several phyto-constituents have been separated from the 
leaves of B. lacera, including 5-hydroxy-3,6,7,3',4'-
pentamethoxy flavone and 5,3',4'-trihydroxy flavone29.  
However, the main anti-cancer effect may be within the  
essential oil composition of leaves. Essential oil composition 
of leaves include thymoquinol dimethyl ether, β-caryophyllene, 
α-humulene and E-β-farnesene30. The α-humulene is an anti-
cancer compound which acts by reactive oxypen species  
induced cytotoxicity, while β-caryophyllene potentiates anti-
cancer activity of α-humulene31. 
 
2.6 Bruguiera gymnorrhiza (L.) Lam.: Bruguiera  
gymnorrhizais (L.) Lam. is commonly known as ‘Large-leafed 
orange mangrove’ and belongs to the Rhizophoraceae family. 
It is known as Kankra (Bangladesh), Malkadol (Sri Lanka), 
and Kandal (India) as well as some local dialect names of B. 
gymnorrhizais. Methanol extract of the bark of B. gymnorrhi-
zais has been reported to have anti-tumor activity in tumor 
bearing mice32. Different organic extracts of B. gymnorrhiza 
leaves have low to moderate cytotoxic activity but are  
selective against human cancer cell lines AGS, HT-29 and 
MDA-MB-435S12. Among several types of phyto-chemicals, 
the role of terpenoids were found to be prominent as anti-
cancer agents33. Ent-kaurane diterpenoids and pimaren 
diterpenoids, isolated from stem of B. gymnorrhiza showed 
moderate cytotoxic activities against L-929 and K562 cancer 
cell lines34. 
 
2.7 Calotropis procera: Calotropis procera, an erect shrub, 
commonly known as ‘Apple of Sodom’. It is a species of 
flowering plant in the Asclepiadaceae family, and locally 
known as Akanda (Bangladesh), Akado (India), Wara (Sri 
Lanka). The organic extracts of stems C. procera have been 
reported to have cytotoxicity against human leukemia cell line 
HL-60, human colon cancer cell line HCT-8 and murine  
melanoma cell line B-16/F10. Stem organic extracts also  
possess anti-tumor activity against mice bearing Sarcoma 180 
tumors35. The chemopreventive effects of C. procera latex is 
reported through the inhibition of different mediators of in-
flammation with selective cytotoxicity independent of intrinsic 
pathway of apoptosis against hepatocellular carcinoma in the 
X15-myc transgenic mouse model36. To reveal the probable 
phyto-chemicals responsible for anti-cancer effect, focus has 
been directed towards heat-stable latex proteins from C. 
procera due to its inhibitory activities on sarcoma 180 
growth37. On the other hand, studies have also emphasized 
non-protein phyto-constituent such as the cardiotonic steroid 
UNBS1450 (8) from C. procera that additionally exert anti-
cancer activity by cytoskeleton disorganization, autophagy-
related cell death induction, NF-κB activation repression as 
well as c-Myc down-regulation in cancer cells38. 
 
2.8 Cuscuta reflexa Roxb.: Cuscuta reflexa Roxb., is a 
golden yellow, leafless, parasitic herb of Convolvulaceae 
family, which is locally known as Swarnalata (Bangladesh), 
Amarvela (India), Aftimiun (Pakistan), Aga mula nethi wel 
(Sri Lanka) and Amar bel. A wide range of pharmacological 
activity of C. reflexa exist such as its anti-spasmodic, anti-
steroidogenic, anti-hypertensive, muscle-relaxant, cardiotonic, 
anti-viral, anti-convulsant, hypoglycemic, anti-fertility,  
hypotensive, anti-inflammatory and anti-epileptic, as well as 
anti-cancer activities have been documented39. In a study, 
chloroform and ethanol extracts of C. reflexa exhibited  
significant anti-tumor activity in EAC-bearing mice that was 
comparable to the effect of 5-fluorouracil40. Another study 
reported that water extract of C. reflexa induced apoptosis in 
Hep3B cells through the up-regulation of pro-apoptotic p53, 
Bax and down regulation of anti-apoptotic Bcl-2 and  
survivin41. The phyto-chemical constituents isolated from C. 
reflexa include cuscutin, amarbelin, β-sterol, stigmasterol, 
kaempferol, dulcitol, myricetin, quercetin, coumarin and 
oleanolic acid, among which, stigmasterol, kaempferol,  
myricetin, and quercetin are known to have anti-cancer  
activity42. 
 
2.9 Dendrophthoe falcata (L.F.) Ettingsh: Dendrophthoe 
falcata is a perennial, climbing, woody parasitic plant of the 
family Loranthaceae. The common name of D. falcata is 
‘Honey Suckled Mistletoe’ but is locally known as Delum 
pilia (Sri Lanka) and Bajrangi (Bangladesh) etc. D. falcate 
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imparts anti-cancer activity as evidenced in cancer cell lines 
and animal models. Ethanolic and aqueous extracts from the 
stem of D. falcata possess high cytotoxic activities against 
human breast cancer cells (MCF-7)43. Ethanol extract of  
D. falcate displayed potent anti-cancer activity against  
EAC-bearing mice. This anti-cancer activity was found  
similar to that of cisplatin44. Hydroalcoholic extract of D.  
falcata showed a protective role against DMBA (7,12-
dimethylbenz(a)anthracite)-induced breast carcinogenesis with 
a concomitant amelioration of antioxidant status. Thus,  
antioxidant activity of D. falcata extract might partially  
contribute to the observed anti-cancer activity, in addition to 
the cytotoxic effect45. The phyto-chemical constituents of  
different part of D. falcate include flavonoids (quercetrin,  
catechin) tannins (gallic acid, chebulinic acid) oleonolic acid, 
β-amyrin-0-acetate, leucocynidin and sterols (β-sitosterol and 
stigmasterol) some of which have been documented as anti-
cancer components46. 
 
2.10 Dioscorea bulbifera L.: Dioscorea bulbifera L.  
belongs to the Dioscoreaceae family and commonly known as 
‘Air potato’. Its local names are Lota-bori (Bangladesh),  
Karukanda (India), Zaminek (Pakistan), and Udala (Sri Lanka). 
D. bulbifera rhizome is used for treatment of leprosy and  
tumors in Bangladesh within an ethno-botanic frame47.  
Investigations showed anti-cancer activity of D. bulbifera in 
several cancers. Various impacts at the molecular level were 
observed regarding different D. bulbifera organic extracts 
treatment. Petroleum ether fraction of D. bulbifera showed 
potential effect against HepA with microstructure abnormality 
of HepA cells surface48. Cui49 reported the modulation of  
immune response and induction of apoptosis by crude poly-
saccharides of D. bulbifera against cervical carcinoma in U14-
bearing mice. Immune system modulation might be related to 
anti-tumor effects of D. bulbifera, as reported in S180 and 
H22 tumor cells bearing mice50. Several phyto-chemicals  
isolated from D. bulbifera are considered as active principle 
for anti-cancer activity, including kaempferol-3, 5-dimethyl 
ether, caryatin, (L)-catechin, myricetin, quercetin-3-O-
galactopyranoside, myricetin-3-O-galactopyranoside, myricetin-
3-O-glucopyranoside and diosbulbin B51. 
 
2.11 Embelia ribes  Burm. F.: Embelia ribes Burm. F. is 
commonly known as ‘False black pepper’, and belongs to the 
Myrsinaceae family. It is locally known as Biranga  
(Bangladesh), Bidang (India), Walangasa (Sri Lanka), and 
Baobadang (Pakistan). A methanol extract of E. ribes fruits 
showed protective effect against multi-mutagenicity and  
genotoxicity, induced by cyclophosphamide in mice, as  
multi-mutagenicty is considered as a molecular basis of  
cancer52. E. ribes contains embelin, quercitol (polyphenols), 
flavonoids, tannins, saponins and alkaloid53,54. Embelin (EB),  
a phenolic compound, is protective against diethyl-
nitrosamine/phenobarbital induced hepatocarcinogenesis in 
rat55. Embelin also has the capacity to protect against acetic 
acid induced ulcerative colitis in rats56. This compound exerts 
its anti-cancer activity by cytotoxicity toward cancer cells 
through the induction of apoptosis, characterized by the  
accumulation of cells in the sub G1 phase, positive annexin-V 
binding, down-regulation of anti-apoptotic (Bcl-2, Bcl-xL, 
survivin, IAP-1, and IAP-2) and proliferative (cyclin D1)  
proteins, activation of caspase-3, and cleavage of PARP56. 
2.12 Ficus benghalensis L.: Ficus benghalensis L. is  
commonly known as ‘Indian Banyan’. It is locally known as 
Bot (Bangladesh), Bargad (India), Gotu Nuga (Sri Lanka), and 
belongs to the family Moraceae. Although there was immuno-
modulatory activity demonstrated using a methanol extract of 
F. benghalensis roots in an animal model57, only an in vitro 
study exists in support of its anti-tumor activity of this plant. 
Hawary et al.58 reported the methanol extract of F.  
benghalensis as a weak anti-tumor agent against HepG2 and 
MCF-7 tumor cell lines at a lower extant. However, this report 
might not represent the actual anti-cancer potential of F.  
benghalensis as suggested by the phyto-chemical constituent 
make up of F. benghalensis. Phyto-chemical analysis revealed 
the presence of several potential anti-cancer agents in different 
parts of plants especially in the leaves (i.e., lupeol, psoralen 
and β-sisterol)59–62. 
 
2.13 Ficus religiosa L.: Ficus religiosa L. is commonly 
known as ‘Bo-tree’, and belongs to the Moraceae family. It is 
locally known as Pan Bot (Bangladesh), Pipli (India), Bo (Sri 
Lanka) and Pippal (Pakistan). In a study, methanol and water 
extract of F. religiosa exhibited cyto-toxicity activity against 
HT29 and MDA-MB-435S cancer cells12, but with more  
selective fractionation, the anti-cancer effect was increased in 
efficiency, as reported in a MCF-7 cell line63. F. religiosa  
contains a wide range of phyto-chemicals like phenols, amino 
acids, fatty acids, tannins, steroids, alkaloids and flavonoids 
are distributed throughout the different parts of plant. However, 
the anti-cancer activity specifically focuses on the several  
phyto-constituents including flavonols i.e. quercetin and  
myricetin, and phytosterols namely stigmasterol and β-
sitosterol64. 
 
2.14 Hibiscus tiliaceus Linn.: Hibiscus tiliaceus Linn. is 
commonly known as ‘Sea Hibiscus’ and belongs to the  
Malvaceae family. It is locally known as Bhola (Bangladesh), 
Bilepatta (Sri Lanka), and Pola (India). H. tiliaceus roots have 
been reported to have anti-cancer activity against Dalton’s 
Ascitic Lymphoma (DAL) in mice65. The cytotoxicy of an 
aqueous extract from H. tiliaceous leaves have also been 
demonstrated against gastric and colon cancer cells12. The 
various phyto-chemicals isolated from the plant are hibiscusin, 
hibiscus amide, vanillic acid, P-hydroxybenzoic acid, syringic 
acid, P-hydroxybenzaldehyde, scopoletin, N-tras-feruloyl-
tyramine, N-cis-feruloyltyramine, β-sitosterol, stigmasterol, β-
stigmasteronone, hibiscolactone, hibiscones, hibiscoqinones, 
lapachol, gossypol, gossypetin, manosonones, hyperoside, 
kaempferol, quercetin, gossypitin, gossytrine, para-coumaric 
and fumaric acid66,67. H. tiliaceus might possess a vast array of 
anti-cancer phyto-chemicals and might have potential to 
emerge due to the presence of known anti-cancerous photo-
chemicals such as β-sitosterol, quercetin, kaempferol etc. 
 
2.15 Jatropha gossypiifolia L.: Jatropha gossypiifolia is a 
bushy gregarious shrub belonging to the Euphorbiaceae Family
and commonly known as ‘Bellyache Bush’. It is locally known 
as Lal Bheranda (Bangladesh), Bhenenda (India), Rathu Erandu
(Sri Lanka). Beyond the ethno-botanic use as an anti-cancer 
plant, there exist no direct evidence of anti-cancer activity of 
the crude extract of J. gossypiifolia, but phyto-chemicals of J. 
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gossypiifolia have been examined and are promising as anti-
cancer agents. The reported phyto-chemical constituents  
include lignans and several diterpenoids, such as falodone (9) 
and jatrophone (10)68,69. Falodone has potent proliferation 
inhibitory activity in A-549 human cancer cell line70, while 
Jatrophone exhibits anti-cancerous properties against P338 
lymphocytic leukemia71. 
 
2.16 Kaempferia parviflora Wall.: Kaempferia parviflora 
Wall. Baker is a stemless, small, rhizomatous herb, commonly 
known as ‘Thai Ginseng’. It is a member of the ginger family 
(Zingiberaceae), and is locally known as ‘Kalahalood’. The 
ethanolic extract of K. parviflora rhizome is effective in  
suppressing the growth of HL-60 human leukemic cells72. This 
effect was found to be associated with the hallmarks of  
apoptotic cell death i.e., morphological cell change, loss in 
mitochondrial transmembrane potential and activation of 
caspase. Similar effect was observed using the crude ethanol 
extract of K. parviflora as reported in cholangio-carcinoma 
cell lines HuCCA-1 and RMCCA-1, where 5,7,4′-
trimethoxyflavone (11) was identified as the anti-cancer  
bioactive component73. Moreover, 3,5,7,4′-
tetramethoxyflavone, 5,7,4′-trimethoxyflavone and 5-hydroxy-
3,7,3′,4′-tetramethoxyflavone purified from its rhizome  
extracts induces cytoxicity in human colorectal carcinoma 
(HCT-15) cells74. 
 
2.17 Lantana camara L.: Lantana camara L. is a species of 
flowering plant from the Verbenaceae family, and is commonly
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known as ‘Spanish Flag’. The local name of L. camara is 
‘Urusia’ in Bangladesh, ‘Caturang’ in India, and ‘Gandapata’ 
in Sri Lanka. Initally, the toxicity of L. camera in some animal 
species drew the attention of scientists, who revealed its anti-
cancer effect75. Mahato et al.76 isolated a novel flavonol  
glycoside, named camaraside (12), an anti-tumor agent from L. 
camera76. In addition, Sharma et al.77 showed that lantadene A 
(13), a torpedoed component of L. camera, induced concentra-
tion and time-dependent inhibition of HL-60 cell proliferation 
by cell cycle arrest in the G0/G1 phase. Lantadene A also  
induced efficient HL-60 cell apoptosis by activating the  
caspase-3 pathway, and via the down- and up-regulation of 
Bcl-2 and Bax expression respectively77. 
 
2.18 Leea indica (Burm.f.) Merr.: Leea indica (Burm.f.) 
Merr., is a large shrub with ribbed branches and swollen nodes, 
belonging  to the Leeaceae family. It is locally known as  
Kukur jiwa (Bangladesh), Kurkurjihva (India), Burulla (Sri 
Lanka) while its common name is ‘Bandicoot Berry’. It was 
reported that methanol extract of L. indica slows the growth of 
EAC in Swiss albino mice, and reduces tumor weight78. The 
crude ethanol extract of L. indica and its ethyl acetate, hexane 
and water fractions showed cytotoxicity on various cancer cell 
lines, such as, Ca Ski, MCF 7, MDA-MB-435, KB, HEP G2 
and WRL 6879. Two cycloartane triterpenoid glycosides, 
namely mollic acid arabinoside (MAA, 14) and mollic acid  
xyloside (MAX, 15) were isolated from L. indica with a  
concomitant demonstration of their anti-cancer effect. Both 
MAA and MAX are effective against the growth of cervical 
cancer cell line Ca Ski80. The cytotoxicity of MAA was  
characterized by both cytostatic and cytocidal effects.  
Specifically, MAA decreases the expression of proliferative 
cell nuclear antigen, increases sub-G1 cells, and arrest cells in 
S and G2/M phases80. 
 
2.19 Mollugo pentaphylla Linn.: Mollugo pentaphylla 
Linn., a perennial herb, is a member of Molluginaceae family 
that is commonly known as ‘Itch Flower’. Its local names  
include ‘Khetpapra (Bangladesh), and Jaraasi (India). In  
chemically induced model of carcinogenesis (DMBA is used 
as a carcinogen and TPA as a tumor initiator), methanol  
extract of M. pentaphylla showed significant anti-tumor  
activity81. As an ingredient of Peh-Hue-Juwa-Chi-Cao,  
traditional Chinese medicine preparations, M. pentaphylla 
exhibited anti-tumor activity against sarcoma-180 cells  
implanted subcutaneous tumors82. Several phyto-chemicals 
isolated from this plant include flavones such as apigenin and 
mollupentin, triterpenoids such as mollugogenol A,  
mollugogenol B, mollugogenol D, oleanolic acid and a steroid 
β-sitosterol83, among which, apigenin, oleanolic acid,  
β-sitosterol have been implicated to possess an anti-cancer  
potential. 
 
2.20 Murraya koenigii Linn.: Murraya koenigii Linn., is a 
plant belonging to the Rutaceae family and commonly known 
as ‘Curry leaf tree’. The local name of M. koenigii are Bar 
Sunga (Bangladesh), Mitha neem (India), and Karapincha (Sri 
Lanka). Muthumani et al.84 found that the non-polar extract of 
M. koenigii caused potent cytotoxic effect during short-term 
incubation (for 3 hours) in DAL cells. They have demonstrated
that M. koenigii significantly decreases the viability and 
growth of DAL cells, when injected intraperitoneally into the 
mice, which was comparable to the effect of 5-flurouracil84. 
The alkaloids mahanine (16), mahanimbicine (17) and  
mahanimbine (18) were isolated from M. koenigii, and showed 
a significant anti-tumor activity against MCF-7, HeLa and 
P388 cell lines85. Mahanine induces the death receptor-
mediated extrinsic pathway of apoptosis in MOLT-3 cancer 
cells, while also inducing the mitochondria dependent intrinsic 
pathway of apoptosis in HL-6086,87. Furthermore, 34 essential 
oils have been isolated from the leaves of M. koenigii, and all 
of which showed potent anti-bacteria and cytotoxic effects in a 
dose dependent trend85. These essential oil included 12  
oxygenated monoterpenes, 12 sesquiterpene hydrocarbons, 
nine oxygenated sesquiterpenes and one oxygenated diterpene. 
 
2.21 Nelumbo nucifera Willd.: The plant Nelumbo nucifera 
Willd., belongs to the family Nelumbonaceae, and popularly 
known as ‘Sacred Lotus’. It is locally known as Kamal (India), 
Nelum (Sri Lanka), Nilufer (Pakistan) and and Padam  
(Bangladesh). During an in vivo study using the hydroethanolic
extract of N. nucifera, there was noticable inhibition of growth 
and also the survival in mice who were intraperitonealy  
injected EAC cells, by modulating lipid peroxidation and 
augmenting antioxidant defense systems in EAC bearing 
mice88. Hemanth et al.89 reported a similar effect of acetone 
extract of N. nucifera leaves in EAC bearing animals, and a 
significant cytotoxicity against HBL-100 in vitro. Also, the 
methanol extracts exhibited significant anti-proliferative effect 
in Calu-6 human pulmonary carcinoma and SMU-601 human 
gastric carcinoma cells89. Repeated reports confirm that the 
major constituents present in the N. nucifera are alkaloids 
(liensinine, neferine, pronuciferine, isoliensinine, negferine, 
asimilobine, nuciferine, remrefidine, isoliensinine etc.) and 
flavonoids, glycosylated flavonols, flavonol, aglycones (myri-
cetin, quercetin, leucocyanidin, rutin, kaempferol, isorhamnet-
in, astragalin etc.)90,91. Neferine (19), a major alkaloid compo-
nent in N. nucifera embryos, possessed a potent growth-
inhibitory effect in human osteosarcoma cells, with a mecha-
nism of p21-dependent cell cycle arrest at G1 due to p38 
MAPK-mediated p21-stabilizing effect of neferine91. 
 
2.22 Nyctanthes arbor-tristis L.: Nyctanthes arbour-tristis 
L. is an evergreen shrub, commonly known as ‘Binari’ which 
is a member of Oleaceae family. Its local names are Sheuli 
(Bangladesh), Harsingar (India), Sepalika (Sri Lanka) and 
Srigading (Indonesia). Ethanolic extract of N. arbor-tristis 
stem bark showed significant anti-cancer activity against DAL 
in Swiss Albino mice92. Kumari et al.93 observed a cytotoxic 
effect of a methanol extract of the dried leaf, fruit and stem in 
MDA-MB231 breast cancer cell line. To date, glycosides are 
found to be the most prominent phyto-chemical isolated from 
the petals, leaves, seeds and flowers of N. arbor-tristis. These 
glycosides include iridoid glycosides (arbortristosides A–C, 
nyctanthoside, arborside-C etc.), phenylpropanoid glycosides, 
carotenoid glucosides, phenylpropanoid glycoside (nyctoside 
A) and cardiac glycosides. Recent researches also reported the 
isolation of polysaccharides, β-sitosterol, β-amyrin,  
hentri-acontane, benzoic acid, nyctanthic acid, friedelin and 
lupeol and oleanolic acid and 6β-hydroxylonganin, alkaloids, 
phlobatanins, terpenoids from N. arbor-tristis94,95. 
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2.23 Oxalis corniculata Linn.: Oxalis corniculata Linn., is 
a small creeping, low growing herbaceous plant, and is a 
member of the Oxalidaceae family, commonly known as  
‘Indian Sorrel’. It is locally known as Amrul (Bangladesh), 
Tipatia (India), Embul embiliya (Sri Lanka), Khatt-i-buti  
(Pakistan). The ethanolic extract of O. corniculata was found 
effective in inhibiting the tumor growth in EAC inoculated 
mice96. 
 
2.24 Physalis minima L.: Physalis minima L., a perennial 
herb which belongs to the Solanaceae family, and is 
commonly known as the ‘Sun Berry’’. It is locally known as 
Potka (Bangladesh) and Bandapariya (India). Studies 
repeatedly pronounced the striking anti-cancer effect of P. 
minima against several cancer cell lines. The chloroform 
extract of P. minima produced a significant growth inhibition 
in human T-47D breast carcinoma cell death via p53, caspase-
3, and c-myc-dependent apoptotic pathways97. A combined 
effect of apoptotic and autophagic programmed cell death was 
found by chloroform extract of P. minima in cytotoxicity 
against Caov-3 cells98. The induction of this programmed cell 
death was mediated via c-myc, p53 and caspase-3 dependent 
pathway. The chloroform extract of P. minima also exhibited 
remarkable cytotoxic activities in NCI-H23 human lung 
adenocarcinoma cell line via apoptotic cell death99. Moreover, 
Ma et al.100 isolated a panel of withanolides from this plant, 
which have moderate cytotoxic activity against human 
colorectal-carcinoma HCT-116 and human non small-cell 
lung-cancer NCI-H460 cell lines. 
 
2.25 Pterocarpus santalinus L.f.: Pterocarpus santalinus 
L.f. belongs to the Fabaceae family, and commonly known as 
‘Red sandalwood’. Its local names are Rat handun (Sri Lanka), 
Lal-chandan (India), and Burada Sandal Safaid (Pakistan). 
Kwon et al. first documented the anti-cancer effect of P.  
santalinus101. Interestingly, in HeLa human cervical  
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santalinus, growth was inhibited and apoptosis induced, as 
confirmed a cell viability assay, chromatin condensation, DNA 
fragmentation and sub-G1 phase accumulation. Phyto-
chemical investigations showed the presence of sesquiterpenes, 
isoflavones, lignans, and aurone glycosides102. Recently, Wu et 
al.103 isolated five new benzofurans, pterolinuses A–E (20–24), 
six new neo-flavonoids, pterolinuses F–J, dehydromelanoxin,  
melanoxin (25), melanoxoin, S-3ʹ-hydroxy-4,4ʹ-dimethoxy-
dalbergione and melannein from the extract of P. santalinus 
heartwood. Among the neoflavonoids, melanoxoin showed 
potent cytotoxicity against Ca9-22, S-3-hydroxy-4,4-
dimethoxydalbergione showed cytotoxicity against Hep3B and 
MDA-MB-231, and pterolinus Hb exhibited cytotoxicity 
against A549 cancer cell lines103. Among the benzofurans, 
pterolinus-B showed cytotoxicity against A549 and MCF7 cell 
lines, while pterolinus-D showed cytotoxicity against Hep3B 
and MCF7 cell lines103. 
 
2.26 Salix tetrasperma Roxb.: Salix tetrasperma Roxb. 
(Family: Salicaceae), is commonly known as ‘Indian Willow’, 
Badah (India), and Burg Baid Sada (Pakistan). In a study, 
Islam et al.104 observed the in vivo cytotoxic activity of the 
organic extract of S. tetrasperma against EAC tumor bearing 
mice. Phyto-chemical studies of S. tetrasperma resulted in the 
isolation of several tannins, triterpenes, viz. β-amyrin, lupeol, 
chalcinasterol, steroids (viz. β-sitosterol and stigmasterol)105. 
 
2.27 Solanum nigrum Linn.: Solanum nigrum Linn. 
belongs to the Solanaceae family, and commonly known as 
Black Nightshade. It is locally known as Kack-machi 
(Bangladesh), Bandakh (India), Kalu Kamberiya (Sri Lanka), 
and Ab Makoh (Pakistan). Extracts from S. nigrum was found 
to induce a strong cytotoxic effect in HepG2 hepatoma cells 
and AU565 breast cancer cells by inducing apoptosis and/or 
autophagocytosis106,107. Actually, a low dose treatment induced 
only autophagy, while high dose treatment induced both of 
autophagy and apoptosis. Although various parts of the S. 
nigrum plant contain polyphenols, gentisic acid, luteolin, 
apigenin, kaempferol, m-coumaric acid, anthocyanidin, their 
role in apoptosis is not clear. The crude polysaccharides from 
S. nigrum concomitantly up-regulates pro-appototic gene Bax 
and down-regulates Bcl-2 and mutant p53 gene expression in 
mice bearing cervical cancer (U14)108. On the other hand, 
pepsin and pancreatin digestion resistant peptide Lunasin has 
been claimed as a bioactive and bioavailable component due to 
inhibition of H3 and H4 acetylation and the phosphorylation of 
the Rb protein in mammalian cells and in a skin cancer mouse 
model109. 
 
2.28 Tinospora crispa: Tinospora crispa is an indigenous 
climber plant that is locally known as Akar Patawali in 
Bangladesh and Geta Kinda in Sri Lanka. It is a member of the 
Menispermaceae family. Several studies suggested the 
efficient cytoxicity of T. crispa polar extracts. Aqueous crude 
extract of T. crispa was treated against MCF-7, HeLa, HepG2 
and Caov-3 cancer cell lines, using cisplatin and tamoxifen as 
standard in a study by Zulkhairi et al.110. The extract exhibited 
anti-proliferative activity in all cancer cell lines, which was 
comparable with standard drugs110. Ibahim et al.111 also treated 
several cancer cell lines (MCF-7, MDA-MB-231, HeLa and 
3T3) with water, methanol or chloroform extract of T. crispa 
stem, and reported a dose-dependent anti-proliferative activity 
against all cancerous cell lines with the most potent effect of 
methanol extract on MDA-MB-231 and MCF-7111. The 
antiproliferative effect of T. crispa might be due to its 
chemical substances especially alkaloids, which are known to 
have anti-cancer properties. Several alkaloids have been 
isolated, namely tinoscorside A (26), N-formylanonaine (27), 
N-formyldehydroanonaine (28), N-formylnomuciferine (29), 
N-demethyl-N-formyldehydronornuciferine (30), magnoflorine
(31), paprazine (32), N-trans-feruloyltyramine (33), N-
formylasimilobine 2-O-β-D-glucopyranoside (34) from T. 
crispa112. 
 
2.29 Tragia involucrate L.: Tragia involucrata L. is a 
member of the Euphorbiaceae family, and commonly known 
as ‘Stinging Nettle’. It is locally known as Bichuti 
(Bangladesh), Barhanta (India), Wel Kahambiliya (Sri Lanka). 
T. involucrate was found to have anti-cancer activity both in 
vitro and in vivo model system. The hexane and ethyl acetate 
extracts of T. involucrata significantly increased the life span 
of EAC baring mice in a dose dependant manner113. Phyto-
chemical analysis of T. involucrata showed the presence of 
flavonoids and terpenoids that were claimed to have possess 
anti-cancer activity, and probably explain the cytotoxic effect 
of T. involucrate extract114. 
 
2.30 Vitex negundo L.: Vitex negundo L., commonly 
known as ‘Chaste tree’, belongs to the Verbenaceae family. It 
is locally known as Nishinda (Bangladesh), Nika (Sri Lanka), 
Bana (India), Sambhalu (Pakistan). Ethanolic extract of V. 
negundo leaf showed significant anti-tumor activity against 
DAL bearing Swiss albino mice115. This extract was also found 
to be cytotoxic against mouse lung fibroblast (L-929) cells in 
long term chemosensitive cytotoxic assay115. Saluja et al.116 
also demonstrated cytotoxic activity of acetone and ethanol 
extracts of V. negundo leaves in EAC bearing mice. A known 
flavone, vitexicarpin was isolated from the chloroform-soluble 
extract of the V. negundo leaves that exhibited broad 
cytotoxicity in a human cancer cell line panel117. Zhou et al.118 
isolated a series of lignan compounds known as Vitexins from 
the seed of V. Negundo, and named them as EVn-50. EVn-50 
was found to contain mainly VB1 (6-hydroxy-4-(4-hydroxy-3-
methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-
naphthaldehyde, 35) and VB2 (6-hydroxy-4-(4-hydroxy-3-
methoxyphenyl)-3-hydroxymethyl-5-methoxy-3,4-dihydro-2-
naphthaldehyde, 36). They showed cytotoxic effect on breast, 
prostate and ovarian cancer cells by inducing apoptosis 
through pro-apoptotic process, which is mediated by a 
decreased Bcl-2/Bax ratio and activation of caspases118. 
 
3 Concluding Remarks 
The actual contribution of South Asia toward the anti-
cancer research seems to be deemed and negligible. Being 
third world countries, research facilities are limited, whereas 
natural resourses are abundant. The variation in geography and  
environment of this region provides a rich plant biodiversity, 
many of which can be used as the source of anti-cancer agents. 
As the use of phyto-chemicals in cancer treatment is promising 
and increasing rapidly, the proper scientific study to extract 
chemicals, investigation of their anti-cancer role in details, and 
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clinical studies might be the interesting subject of future  
cancer research. 
 
Open Access This article is distributed under the terms of the  
Creative Commons Attribution License which permits any use,  
distribution, and reproduction in any medium, provided the original 
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